Close

Analyst Ratings for CNS Pharmasceuticals Inc. (CNSP)

CNSP Rating Summary

  |   Expand Research on CNSP
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/17/2022 Maxim Group Jason McCarthy Downgrade Hold
(Buy)
N/A
(N/A)
0.24
(0.21)
-12.5% Details
2/2/2021 Brookline Capital Markets Kumaraguru Raja New Coverage Buy
(N/A)
10.00
(N/A)
1.80
(0.21)
-88.33% Details